December 9, 2014
Otsuka Pharmaceutical and the Danish-based H. Lundbeck A/S said on December 8 that Abilify Maintena (aripiprazole), a once-monthly extended-release injectable suspension of the antipsychotic agent Abilify, has received approval for an additional indication of the treatment of acutely relapsed adults...read more